Objectives: Preoperative chronic kidney disease (CKD) has been shown to predict postoperative renal complications and late survival following aortic surgery, whereas the impact of postoperative renal complications less severe than permanent dialysis are unknown. We evaluated the effect of increasingly severe postoperative renal dysfunction on survival using a regional quality improvement registry.
Objectives: In medically high-risk patients, the choice between carotid artery stenting (CAS) and carotid endarterectomy (CEA) can be difficult. The purpose of this study was to compare risk-stratified outcomes of CAS and CEA.
Methods: Patients undergoing primary CEA (n ¼ 10,541) or primary CAS (n ¼ 424) at 26 centers in the Vascular Study Group of New England were analyzed (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) ; patients with prior ipsilateral CEA or CAS were excluded. A medical risk score based on the risk of death within 5 years was developed for each patient using a Cox proportional hazards model. Patients in the highest risk quartile were termed high-risk (vs normal risk for the other three quartiles). Risk-stratified outcomes were compared between neurologically symptomatic and asymptomatic patients.
Results: Patients undergoing CAS had a higher prevalence of coronary artery disease, congestive heart failure, diabetes, chronic obstructive pulmonary disease, and contralateral internal carotid artery occlusion. Neurologic symptom status was not different (CAS, 43% vs CEA, 40% symptomatic). Overall 5-year survival was 80%. Medically high-risk patients had a 5-year survival of 60% and comprised 25% of CEA and 35% of CAS. Among asymptomatic patients rates of in-hospital stroke/death, and stroke/death/myocardial infarction were not different between CAS and CEA in both normal-and high-risk cohorts. Among symptomatic patients, CAS had significantly higher event rates for both normal-and high-risk cohorts (Table) . CAS outcomes did not correlate with operator annualized stent volume.
Conclusions: In the Vascular Study Group of New England, asymptomatic normal-and high-risk patients do equally well after CEA or CAS. However, both normal-and high-risk symptomatic patients have substantially worse outcomes with CAS as compared with CEA. Symptom status is more important than medical risk when recommending CAS. Results: Examined were 2,377,166 ESRD patients. We excluded all patients with IHC, AVF, or AVG prior to 2006, those not classified as white, black, or Hispanic, and patients with prior kidney transplants. Patients totaling 482,988 were included, of whom 82.7% initiated HD via IHC versus 13.9% via AVF and 3.4% via AVG. White patients were older (65.9 years) at initiation than black (58.4 years) and Hispanic (58.0 years) patients (P < .001). Black patients were more likely to be female (48.1%) than white (41.2%) and Hispanic (42.9%) patients (P < .001). HD initiation with AVF was more common among white patients (15.2%) than black (12.5%) or Hispanic (11.8%) patients, whereas AVG was more common among black patients (4.9%) than white (2.9%) or Hispanic (2.6%) patients (P < .001; Table) .
Racial Disparity in Hemodialysis Access
Conclusions: White ESRD patients initiate HD with AVF more frequently than black or Hispanic patients. This disparity between white and black patients derives not from procedure rate, but rather from conduit selection. Black patients receive AVG two-thirds more frequently, while undergoing surgery at clinically similar rates. Hispanic patients receive fewer fistulas and grafts, as well as more catheters, in comparison to the other 
